COVID-19 Vaccines Evidence Summary HTAC Press Release

HTAC RECOMMENDS COVID-19 VACCINE MODERNA UNDER EMERGENCY USE FOR REDUCING COVID-19 RISK IN PERSONS AGED 18 AND OLDER

HTAC RECOMMENDS COVID-19 VACCINE JANSSEN UNDER EMERGENCY USE FOR REDUCING COVID-19 RISK IN PERSONS AGED 18 AND OLDER

HTAC RECOMMENDS GAMALEYA COVID-19 VACCINE SPUTNIK V UNDER EMERGENCY USE FOR REDUCING COVID-19 RISK IN PERSONS AGED 18 AND OLDER

HTAC RECOMMENDS COVID-19 VACCINE SINOVAC UNDER EMERGENCY USE FOR REDUCING COVID-19 RISK IN PERSONS AGED 18 AND OLDER

HTAC recommends COVID-19 Vaccine AstraZeneca under emergency use for reducing COVID-19 risk in persons aged 18 and older

HTAC recommends Pfizer-BioNTech COVID-19 Vaccine under emergency use for reducing COVID-19 risk in persons aged 16 and older

HTA Philippines publishes HTAC Evaluation Framework for COVID-19 Vaccines

HTAC recommends pooled RT-PCR testing to monitor COVID transmission in populations with low case numbers

HTAC recommends high-flow nasal cannula oxygen therapy for severe COVID-19